RxSight (RXST) Change in Accured Expenses (2020 - 2026)

RxSight (RXST) has 7 years of Change in Accured Expenses data on file, last reported at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 79.64% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 11.91% YoY), and the FY2025 full-year result was -$1.9 million, down 131.95% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$1.3 million, down from $1.7 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.7 million in Q3 2024 and bottomed at -$6.2 million in Q1 2025.
• The 5-year median for Change in Accured Expenses is $1.6 million (2025), against an average of $580352.9.
• Peak annual rise in Change in Accured Expenses reached 91.9% in 2022, while the deepest fall reached 191.16% in 2022.
• A 5-year view of Change in Accured Expenses shows it stood at $2.4 million in 2022, then retreated by 9.52% to $2.2 million in 2023, then jumped by 58.72% to $3.5 million in 2024, then tumbled by 51.26% to $1.7 million in 2025, then plunged by 173.91% to -$1.3 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.3 million (Q1 2026), $1.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.

Peer Comparison